56 related articles for article (PubMed ID: 10550664)
41. Determinants of enhancer and promoter activities of regulatory elements.
Andersson R; Sandelin A
Nat Rev Genet; 2020 Feb; 21(2):71-87. PubMed ID: 31605096
[TBL] [Abstract][Full Text] [Related]
42. Integrative approaches to study enhancer-promoter communication.
Mach P; Giorgetti L
Curr Opin Genet Dev; 2023 Jun; 80():102052. PubMed ID: 37257410
[TBL] [Abstract][Full Text] [Related]
43. Long-range enhancer-promoter contacts in gene expression control.
Schoenfelder S; Fraser P
Nat Rev Genet; 2019 Aug; 20(8):437-455. PubMed ID: 31086298
[TBL] [Abstract][Full Text] [Related]
44. Viral enhancer mimicry of host innate-immune promoters.
Kropp KA; Angulo A; Ghazal P
PLoS Pathog; 2014 Feb; 10(2):e1003804. PubMed ID: 24516378
[No Abstract] [Full Text] [Related]
45. The use of cloned gene probes to study differentiation in teratocarcinomas.
Goodfellow PN
Cell Differ; 1984 Dec; 15(2-4):257-67. PubMed ID: 6399010
[TBL] [Abstract][Full Text] [Related]
46. Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology.
Urbina F; Morales-Pison S; Maldonado E
Polymers (Basel); 2020 Jul; 12(8):. PubMed ID: 32717794
[TBL] [Abstract][Full Text] [Related]
47. The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers.
Shigekane H; Kawaguchi Y; Shirakata M; Sakaguchi M; Hirai K
Arch Virol; 1999; 144(10):1893-907. PubMed ID: 10550664
[TBL] [Abstract][Full Text] [Related]
48. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
[TBL] [Abstract][Full Text] [Related]
49. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication.
Parcells MS; Arumugaswami V; Prigge JT; Pandya K; Dienglewicz RL
Poult Sci; 2003 Jun; 82(6):893-8. PubMed ID: 12817443
[TBL] [Abstract][Full Text] [Related]
50. A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24.
Izumiya Y; Jang HK; Ono M; Mikami T
Curr Top Microbiol Immunol; 2001; 255():191-221. PubMed ID: 11217423
[No Abstract] [Full Text] [Related]
51. Protein-coding content of the sequence of Marek's disease virus serotype 1.
Lupiani B; Lee LF; Reddy SM
Curr Top Microbiol Immunol; 2001; 255():159-90. PubMed ID: 11217422
[No Abstract] [Full Text] [Related]
52. The genomic structure of Marek's disease virus.
Silva RF; Lee LF; Kutish GF
Curr Top Microbiol Immunol; 2001; 255():143-58. PubMed ID: 11217421
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
